Next Article in Journal
Quantification of Differential ECMO Return Flow Through an Axillary Artery Anastomosis Graft with Spectral Doppler Echocardiographyphy
Previous Article in Journal
Hypertensive Herzkrankheit – zur Diagnoseist der Nachweis Einer Linksventrikulären Hypertrophie Nicht Nötig
 
 
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Swiss Society of Cardiology Cardiovascular Biology Prize †

by
Swiss Society of Cardiology
Karin Guldenfels, Schwarztorstrasse 18, 3007 Bern, Switzerland
An Official Scientific Prize of the Swiss Society of Cardiology SGK/SSC Secretariat: Schwarztorstrasse 18, 3007 Bern.
Cardiovasc. Med. 2014, 17(2), 68; https://doi.org/10.4414/cvm.2014.00219
Submission received: 19 November 2013 / Revised: 19 December 2013 / Accepted: 19 January 2014 / Published: 19 February 2014
Cardiovascmed 17 00068 i001

Rules for entry

  • The Cardiovascular Biology Prize is awarded for original research work in cardiovascular disease.
  • Prizes may be awarded for one or more research projects (up to a maximum of three) provided that they are connected.
  • The manuscripts should be published or accepted for publication in a recognised peer reviewed journal. Only to work published in the year in which the prize is awarded or in the years immediately preceding of following it can be considered.
  • Applicants should be the principal author of the work being submitted. Should several works be submitted, the applicant should be the principal author of at least one of them.
  • Applicants must be under 40 years of age on the deadline for submission. They must be Swiss citizens or working in Switzerland. Swiss citizens may also submit work carried out abroad provided that they are working in Switzerland at the time of the award.
  • The prize will be awarded annually by the Swiss Society of Cardiology, normally at the Annual Conference, but exceptionally at another event sponsored by the Society.
  • The prize winners will be selected by a prize jury whose members will be nominated by the Swiss Society of Cardiology by agreement with the cosponsor Pfizer. The jury will consist of a chairman, representatives of all Swiss universities and the members of the board of Swiss Society of Cardiology, as well as international experts. Members of the jury will be elected for four years and may be re-elected. A representative of Pfizer will be included as an observer.
  • The prize will be CHF 30,000.00, partly donated by Pfizer.
  • The prize winner must undertake to use the prize money of CHF 30,000.00 exclusively to continue his or her research. The money may be used for salaries, equipment or disposable materials.
Applications should be submitted by April 6, 2 014, by e-mail to: info@swisscardio.ch
Cardiovascmed 17 00068 i002

Share and Cite

MDPI and ACS Style

Swiss Society of Cardiology. Swiss Society of Cardiology Cardiovascular Biology Prize. Cardiovasc. Med. 2014, 17, 68. https://doi.org/10.4414/cvm.2014.00219

AMA Style

Swiss Society of Cardiology. Swiss Society of Cardiology Cardiovascular Biology Prize. Cardiovascular Medicine. 2014; 17(2):68. https://doi.org/10.4414/cvm.2014.00219

Chicago/Turabian Style

Swiss Society of Cardiology. 2014. "Swiss Society of Cardiology Cardiovascular Biology Prize" Cardiovascular Medicine 17, no. 2: 68. https://doi.org/10.4414/cvm.2014.00219

APA Style

Swiss Society of Cardiology. (2014). Swiss Society of Cardiology Cardiovascular Biology Prize. Cardiovascular Medicine, 17(2), 68. https://doi.org/10.4414/cvm.2014.00219

Article Metrics

Back to TopTop